CBA to FDA: Urgent action required on CBD regulation | 2021-07-29

WASHIINGON — The Consumer Brands Association on July 22 renewed its call for urgent government action on cannabidiol (CBD) regulation in letters addressed to Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration, and Senator Ron Wyden of Oregon, chairman of the Senate Committee on Finance. The letter to Dr. Woodcock from Betsy Booren, CBA’s senior vice president, regulatory affairs, stated the “FDA stance on CBD products is not working” and a regulatory framework for CBD products is “needed now to protect consumers, ensure product safety and transparency, establish guardrails for legal product innovation and distribution in interstate…

CBA to FDA: Urgent action required on CBD regulation | 2021-07-29 Topshelf News.

source https://topshelf.news/cba-to-fda-urgent-action-required-on-cbd-regulation-2021-07-29/